Jobs Lost as Cellectar Biosciences Shutters Manufacturing Operations Post author:Sam Post published:January 8, 2018 Post category:BioPharma Cellectar Biosciences is closing its manufacturing operations and contracting them out. Source: BioSpace You Might Also Like GlaxoSmithKline Is Taking a Tough Approach to Budgets March 20, 2018 3 Key Reasons Why a Gilead-Vertex Marriage May Not be a Match Made in Biotech Heaven July 4, 2017 Johnson & Johnson's Imbruvica Scores Expanded FDA Approval for Chronic Graft vs Host Disease August 2, 2017
Johnson & Johnson's Imbruvica Scores Expanded FDA Approval for Chronic Graft vs Host Disease August 2, 2017
